Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHAPER: Losartan and Hypofractionated Radiation Therapy After Induction Chemotherapy for Pancreatic Cancer
NCT04106856Phase 1Completed
- Sponsor
- University of Utah
- Start
- Aug 2019
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of losartan in pancreatic cancer (PC), sponsored by University of Utah. Primary endpoint: Rate of dose-limiting toxicities. Started Aug 2019; status: completed.
02
Drugs
losartan
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT04106856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04106856.